Skin, drug and chemical reactions

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 2, 2008, Pages

  Alenius, Harri ^a   Roberts, David W ^b   Tokura, Yoshiki ^c   Lauerma, Antti ^a   Patlewicz, Grace ^d   Roberts, Michael S ^e  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d JOINT RESEARCH CENTRE   (Italy)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CD1D ANTIGEN; CD209 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 17; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTEROID ANTIINFLAMMATORY AGENT; PORPHYRIN DERIVATIVE; PSORALEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANITIDINE; SALICYLANILIDE DERIVATIVE; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPARFLOXACIN; SULFANILAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ACNE; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ADAPTIVE IMMUNITY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN PRESENTATION; CONTACT DERMATITIS; CYTOKINE RELEASE; DENDRITIC CELL; DRESS SYNDROME; DRUG ERUPTION; DRUG EXPOSURE; ECZEMA; EXFOLIATIVE DERMATITIS; FIXED DRUG ERUPTION; GINGIVA HYPERPLASIA; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE MIGRATION; LICHENOID ERUPTION; LIPODYSTROPHY; MEASLES LIKE RASH; NONHUMAN; PEMPHIGUS; PHOTOALLERGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PROTEIN EXPRESSION; PRURITUS; PSEUDOPORPHYRIA; REVIEW; SERUM SICKNESS; SIDE EFFECT; SKIN ALLERGY; SKIN INFLAMMATION; SKIN MANIFESTATION; SKIN PIGMENTATION; SKIN SENSITIZATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

EID: 67349256120     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.06.001     Document Type: Review

References (71)

1. Roberts M.S., and Walters K.A. Dermal Absorption Toxicity Assessment. 2nd edn Vol. 326 (2008), Informa Health Care, New York 78
2. Kimber I., et al. Allergic contact dermatitis. Int. Immunopharmacol. 2 (2002) 201-211
3. Guermonprez P., et al. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
4. Sallusto F., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28 (1998) 2760-2769
5. Sallusto F., et al. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18 (2000) 593-620
6. Sozzani S., et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161 (1998) 1083-1086
7. Forster R., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
8. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
9. Geijtenbeek T.B., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
10. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23 (2005) 877-900
11. Campos R.A., et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198 (2003) 1785-1796
12. Bretscher P., and Cohn M. A theory of self-nonself discrimination. Science 169 (1970) 1042-1049
13. Lambrecht B.N. The dendritic cell in allergic airway diseases: a new player to the game. Clin. Exp. Allergy 31 (2001) 206-218
14. Sato T., et al. Consequences of OX40-OX40 ligand interactions in Langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Eur. J. Immunol. 32 (2002) 3326-3335
15. Ptak W., and Askenase P.W. Gamma delta T cells assist alpha beta T cells in adoptive transfer of contact sensitivity. J. Immunol. 149 (1992) 3503-3508
16. Tsuji R.F., et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196 (2002) 1277-1290
17. Yokozeki H., et al. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin. Exp. Immunol. 125 (2001) 351-359
18. Askenase P.W. Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin. Exp. Immunol. 125 (2001) 345-350
19. Askenase P.W., et al. Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. Trends Immunol. 25 (2004) 441-449
20. Szczepanik M., et al. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J. Immunol. 171 (2003) 6225-6235
21. Tsuji R.F., et al. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells. J. Exp. Med. 186 (1997) 1015-1026
22. Tsuji R.F., et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165 (2000) 1588-1598
23. Kondo S., et al. Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J. Invest. Dermatol. 106 (1996) 993-1000
24. Wang B., et al. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165 (2000) 6783-6790
25. Saint-Mezard P., et al. Deficient contact hypersensitivity reaction in CD4-/- mice is because of impaired hapten-specific CD8+ T cell functions. J. Invest. Dermatol. 124 (2005) 562-569
26. Cavani A., et al. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114 (2000) 295-302
27. Traidl C., et al. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J. Invest. Dermatol. 112 (1999) 476-482
28. Nakae S., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
29. Homey B., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8 (2002) 157-165
30. Zhou Y., et al. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol. 160 (1998) 4018-4025
31. Varona R., et al. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest. 107 (2001) R37-R45
32. O'Garra A., and Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10 (2004) 801-805
33. Taylor A., et al. T regulatory cells in allergy and health: a question of allergen specificity and balance. Int. Arch. Allergy Immunol. 135 (2004) 73-82
34. Kehren J., et al. Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J. Exp. Med. 189 (1999) 779-786
35. Tokura Y. Immune responses to photohaptens: implications for the mechanisms of photosensitivity to exogenous agents. J. Dermatol. Sci. 23 Suppl. 1 (2000) S6-S9
36. Tokura Y., et al. sparfloxacin photoxicity: potential photoaugmentation by ultraviolet A and B sources. Arch. Dermatol. Res. 288 (1996) 45-50
37. Tokura Y. Quinolone photoallegy; photosensitivity dermatitis induced by systemic administration of photohaptenic drugs. J. Dermatol. Sci. 18 (1998) 1-10
38. Tokura Y., et al. Genetic control of contact photosensitivity to tetrachlorosalicylanilide. I. Preferential activation of suppressor T cells in low responder H-2K mice. J. Invest. Dermatol. 94 (1990) 471-476
39. Sauvaigo S., et al. Analysis of fluoroquinolone-mediated photosensitization of 2′-deoxyguanosine, calf thymus and cellular DNA: determination of type-I, type-II and triplet-triplet energy transfer mechanism contribution. Photochem. Photobiol. 73 (2001) 230-237
40. Kurita M., et al. Induction of keratinocyte apoptosis by photosensitizing chemicals plus UVA. J. Dermatol. Sci. 45 (2007) 105-112
41. Tokura Y., et al. Afloqualone photosensitivity: immunogenicity of afloqualone-photomodified epidermal cells. Photochem. Photobiol. 60 (1994) 262-267
42. Tokura Y., et al. Photohaptenic properties of fluoroquinolones. Photochem. Photobiol. 64 (1996) 838-844
43. Ohshima A., et al. Formation of antigenic quinolone photoadducts on Langerhans cells initiates photoallergy to systemically administered quinolone in mice. J. Invest. Dermatol. 114 (2000) 569-575
44. Tokura Y., et al. Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vbeta13 by immune T cells that recognize fluoroquinolone-photomodified cells. J. Immunol. 160 (1998) 3719-3728
45. Tokura Y., et al. Quinolone-photoconjugated major histocompatibility complex class II-binding peptides with lysine are antigenic for T cells mediating murine quinolone photoallergy. J. Invest. Dermatol. 117 (2001) 1206-1211
46. Jowsey I.R., et al. A future approach to measuring relative skin sensitising potency: a proposal. J. Appl. Toxicol. 26 (2006) 341-350
47. Roberts D.W., and Aptula A.O. Determinants of skin sensitisation potential. J. Appl. Toxicol. 28 (2008) 377-387
48. Landsteiner K., and Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 64 (1936) 643-655
49. Dupuis G., and Benezra C. Allergic Contact Dermatitis to Simple Chemicals: A Molecular approach (1982), Dekker, New York
50. Ashby J., et al. Structure activity relationships in skin sensitization using the murine local lymph node assay. Toxicology 103 (1995) 177-194
51. Barratt M.D., et al. Structure-activity relationships for contact hypersensitivity. In: Lepoittevin J.-P., Basketter D.A., Goossens A., and Karlberg A.-T. (Eds). Allergic Contact Dermatitis. The Molecular Basis (1997), Springer, Heidelberg 129-154
52. Smith C.K., and Hotchkiss S.A.M. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms (2001), Taylor & Francis, London
53. Roberts D.W., and Williams D.L. The derivation of quantitative correlations between skin sensitisation and physico-chemical parameters for alkylating agents and their application to experimental data for sultones. J. Theor. Biol. 99 (1982) 807-825
54. Patlewicz G., et al. An evaluation of selected global (Q) SARs/expert systems for the predication of skin sensitisation potential. SAR QSAR Environ. Res. 18 (2007) 515-541
55. Roberts D.W., et al. Global (Q) SARs for skin sensitisation - assessment against OECD principles. SAR QSAR Environ. Res. 18 (2007) 343-365
56. Roberts D.W., et al. Electrophilic chemistry related to skin sensitisation. Reaction mechanistic applicability domain classification for a published dataset of 106 chemicals tested in the mouse local lymph node assay. Chem. Res. Toxicol. 20 (2007) 44-60
57. Aptula A.O., and Roberts D.W. Mechanistic applicability domains for non-animal based toxicological endpoints. General principles and application to reactive toxicity. Chem. Res. Toxicol. 19 (2006) 1097-1105
58. Alvarez-Sánchez R., et al. Studies of chemical selectivity of hapten, reactivity, and skin sensitization. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitisers, 5-chloro-2-methylisothiazol- 3-one (MCI) and 2-methylisothiazol-3-one (MI). Chem. Res. Toxicol. 16 (2003) 627-636
59. Karlberg A.-T., et al. Allergic contact dermatitis - formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21 (2007) 53-69
60. Lepoittevin J.-P., et al. Metabolism versus chemical transformation or pro-versus prehaptens?. Contact Dermatitis 54 (2006) 73-74
61. Karlberg A.T., et al. Hydroperoxides in oxidized d-limonene identified as potent contact allergens. Arch. Dermatol. Res. 286 (1994) 97-103
62. Barratt M.D. Structure-activity relationships and prediction of photoallergic and phototoxic potential. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption in Toxicity Assessment. 2nd edn (2006), Informa, New York
63. Ridings J.E., et al. Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology 106 (1996) 267-279
64. Patlewicz G., et al. TIMES-SS - A promising tool for the assessment of skin sensitization hazard. A characterisation with respect to the OECD Validation Principles for (Q)SARs. Regul. Toxicol. Pharmacol. 48 (2007) 225-239
65. Roberts D.W., et al. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential. J. Appl. Toxicol. 28 (2008) 443-454
66. Gerner I., et al. Potential regulatory use of (Q)SARS to develop dermal irritation and corrosion assessment strategies. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment. 2nd edn (2008), Marcel Dekker, New York 495-506
67. Roberts M.S., et al. Solvent and vehicle effects on the skin. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment. 2nd edn (2008), Marcel Dekker, New York 433-447
68. Roberts M.S., et al. Skin hydration - a key determinant in topical absorption. In: Walters K., and Roberts M.S. (Eds). Dermatologic, Cosmeceutic, and Cosmetic Development: Therapeutic and Novel Approaches (2008), Informa, New York 1-10
69. Thong, H.Y. and Maibach, H.I. Irritant dermatitis as a model of inflammation. Drug Discov. Today (in press)
70. Gerner I., et al. Development of (Q)SARS for dermal irritation and corrosion assessment using EU new chemicals notification data. In: Roberts M.S., and Walters K.A. (Eds). Dermal Absorption and Toxicity Assessment. 2nd edn (2008), Marcel Dekker, New York 507-522
71. Roberts M.S., et al. Permeability of human epidermis to phenolic compounds. J. Pharm. Pharmacol. 29 (1977) 677-683